News About: Pharm. Affairs
The NOAC benefit expanssion has heated competition of the anti-coagulant market
By the benefit expansion of the new oral anti-coagulant(NOAC), competition in the NOAC market is expected to be serious.
As the Ministry of Health and Welfare revised and issued the benefit expansion to the primary d...
5083 benefited drugs decreased 2.1% in price, enforced on March next year
Since the Drug Price Adjustment System over Real Transaction Pharmaceutical Price will be applied, drug price of 5,000 listed pharmaceutical products is expected to be decreased by approximately 2%.
The Ministry of H...
Increasing interests towards ‘edoxaban’ due to the NOAC benefit enlargement
Along with the news about the benefit enlargement, the industry has paid attention to the domestic acceptance period of the fourth New Oral Anti-Coagulant(NOAC).
According to the industry concerned on the 29th, Daiic...
The Korea Bio Association established a presence at the U.S. high-tech biopharmaceutical support center
As a part of the U.S. economic mission, the Korea Bio Association announced on the 25th that it has signed a business agreement with the US Texas Healthcare & Bioscience Institute(THBI) on the last 18th of June and es...
The KRW 43 billion ‘Vytorin Tab’ market is noticed by 23 generic products
Domestic pharmaceutical companies have kept eyes on the hyperlipidemia treatment ‘Vytorin Tab’ market, which used to worth KRW 43 billion last year.
According to the Ministry of Food and Drug Safety, 12 pharmaceutica...
The first payment of the ‘Prescribed/Prepared Drug Price Reduction Incentive’
The first incentive payment to encourage the reduction of prescribed/prepared drug price, which has been in the center of interests in the healthcare industry, has been made.
The Ministry of Health and Welfare(Minist...
“The generic substitution is finally about to be opened for pharmacists”
In order to avoid misunderstandings and conflicts caused by follow-up notices of pharmacists for doctors and dentists, a Pharmaceutical Law Amendment was proposed to improve the passive reality towards the generic sub...
80 generics will compete fiercely over the generic market of Celebrex
It is expected that approximately 80-100 generics of the leading product recording KRW 60 billion annual sales in the non-steroidal anti-inflammatory drugs (NASIDs) market, Celebrex, will be fierce among clinic-level ...
Exports of pharmaceutical products continued to increase, expecting $2.12 billion sales this year
Exports of pharmaceutical companies have been continuously increased.
According to Shinhan Investment Corp., the amount of exports of pharmaceutical products on May was $183.86 million increasing 21.7% up compared to...
The scarcity effect of ‘MERS’-related hygiene products is now settled while returning them is worried
While the scarcity effect of hygiene products, such as masks and sanitizers, caused by the Middle East Respiratory Syndrome(MERS) crisis, seems to be settled down, a part of the pharmaceutical distribution industry ha...
